nodes	percent_of_prediction	percent_of_DWPC	metapath
Diethylpropion—obesity—type 2 diabetes mellitus	0.609	1	CtDrD
Diethylpropion—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.0732	0.268	CrCrCtD
Diethylpropion—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.0732	0.268	CrCrCtD
Diethylpropion—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.0711	0.26	CrCrCtD
Diethylpropion—L-Phenylalanine—Nateglinide—type 2 diabetes mellitus	0.0557	0.204	CrCrCtD
Diethylpropion—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00286	0.397	CbGeAlD
Diethylpropion—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00192	0.267	CbGeAlD
Diethylpropion—SLC6A3—nerve—type 2 diabetes mellitus	0.00134	0.186	CbGeAlD
Diethylpropion—Etomidate—SLC2A1—type 2 diabetes mellitus	0.0012	0.471	CrCbGaD
Diethylpropion—SLC6A2—nerve—type 2 diabetes mellitus	0.00108	0.15	CbGeAlD
Diethylpropion—Amphetamine—CARTPT—type 2 diabetes mellitus	0.000739	0.29	CrCbGaD
Diethylpropion—SLC6A3—Dopaminergic Neurogenesis—NKX6-1—type 2 diabetes mellitus	0.000527	0.0692	CbGpPWpGaD
Diethylpropion—SLC6A3—Dopaminergic Neurogenesis—NEUROD1—type 2 diabetes mellitus	0.00049	0.0644	CbGpPWpGaD
Diethylpropion—SLC6A3—Alpha-synuclein signaling—GRK5—type 2 diabetes mellitus	0.000323	0.0424	CbGpPWpGaD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00017	0.0223	CbGpPWpGaD
Diethylpropion—SLC6A2—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.000163	0.0214	CbGpPWpGaD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.00015	0.0198	CbGpPWpGaD
Diethylpropion—SLC6A3—Monoamine Transport—NOS1—type 2 diabetes mellitus	0.000144	0.019	CbGpPWpGaD
Diethylpropion—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000143	0.00142	CcSEcCtD
Diethylpropion—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000143	0.00142	CcSEcCtD
Diethylpropion—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000142	0.00142	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00141	CcSEcCtD
Diethylpropion—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000141	0.0014	CcSEcCtD
Diethylpropion—Levomilnacipran—CYP3A4—type 2 diabetes mellitus	0.00014	0.055	CrCbGaD
Diethylpropion—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00014	0.0014	CcSEcCtD
Diethylpropion—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00014	0.0014	CcSEcCtD
Diethylpropion—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Diethylpropion—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Diethylpropion—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Diethylpropion—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Diethylpropion—Nausea—Repaglinide—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Diethylpropion—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000139	0.00138	CcSEcCtD
Diethylpropion—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000139	0.00138	CcSEcCtD
Diethylpropion—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000139	0.00138	CcSEcCtD
Diethylpropion—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000138	0.00138	CcSEcCtD
Diethylpropion—Erythema—Metformin—type 2 diabetes mellitus	0.000138	0.00137	CcSEcCtD
Diethylpropion—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000137	0.00136	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000136	0.00136	CcSEcCtD
Diethylpropion—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000135	0.00134	CcSEcCtD
Diethylpropion—Malaise—Orlistat—type 2 diabetes mellitus	0.000135	0.00134	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000134	0.0176	CbGpPWpGaD
Diethylpropion—Palpitations—Valsartan—type 2 diabetes mellitus	0.000134	0.00133	CcSEcCtD
Diethylpropion—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000133	0.00133	CcSEcCtD
Diethylpropion—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000133	0.00133	CcSEcCtD
Diethylpropion—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000133	0.00132	CcSEcCtD
Diethylpropion—Palpitations—Orlistat—type 2 diabetes mellitus	0.000132	0.00131	CcSEcCtD
Diethylpropion—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000132	0.00131	CcSEcCtD
Diethylpropion—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000132	0.00131	CcSEcCtD
Diethylpropion—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000131	0.00131	CcSEcCtD
Diethylpropion—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Diethylpropion—Erythema—Irbesartan—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Diethylpropion—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Diethylpropion—Vision blurred—Metformin—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Diethylpropion—Convulsion—Orlistat—type 2 diabetes mellitus	0.000129	0.00129	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000129	0.00129	CcSEcCtD
Diethylpropion—Tremor—Metformin—type 2 diabetes mellitus	0.000129	0.00128	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000129	0.0169	CbGpPWpGaD
Diethylpropion—Chest pain—Valsartan—type 2 diabetes mellitus	0.000129	0.00128	CcSEcCtD
Diethylpropion—Myalgia—Valsartan—type 2 diabetes mellitus	0.000129	0.00128	CcSEcCtD
Diethylpropion—Dizziness—Glipizide—type 2 diabetes mellitus	0.000129	0.00128	CcSEcCtD
Diethylpropion—Anxiety—Valsartan—type 2 diabetes mellitus	0.000128	0.00128	CcSEcCtD
Diethylpropion—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000128	0.00127	CcSEcCtD
Diethylpropion—Tension—Irbesartan—type 2 diabetes mellitus	0.000128	0.00127	CcSEcCtD
Diethylpropion—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000127	0.00127	CcSEcCtD
Diethylpropion—Myalgia—Orlistat—type 2 diabetes mellitus	0.000127	0.00127	CcSEcCtD
Diethylpropion—Chest pain—Orlistat—type 2 diabetes mellitus	0.000127	0.00127	CcSEcCtD
Diethylpropion—Anxiety—Orlistat—type 2 diabetes mellitus	0.000127	0.00126	CcSEcCtD
Diethylpropion—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000126	0.00126	CcSEcCtD
Diethylpropion—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000126	0.00125	CcSEcCtD
Diethylpropion—Discomfort—Orlistat—type 2 diabetes mellitus	0.000126	0.00125	CcSEcCtD
Diethylpropion—Tiaprofenic acid—PTGS2—type 2 diabetes mellitus	0.000126	0.0492	CrCbGaD
Diethylpropion—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000125	0.00125	CcSEcCtD
Diethylpropion—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000125	0.00125	CcSEcCtD
Diethylpropion—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000124	0.00124	CcSEcCtD
Diethylpropion—Malaise—Metformin—type 2 diabetes mellitus	0.000124	0.00124	CcSEcCtD
Diethylpropion—Alopecia—Losartan—type 2 diabetes mellitus	0.000124	0.00124	CcSEcCtD
Diethylpropion—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000124	0.00124	CcSEcCtD
Diethylpropion—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000124	0.00123	CcSEcCtD
Diethylpropion—Vomiting—Glipizide—type 2 diabetes mellitus	0.000124	0.00123	CcSEcCtD
Diethylpropion—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000123	0.00123	CcSEcCtD
Diethylpropion—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000123	0.00123	CcSEcCtD
Diethylpropion—Rash—Glipizide—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.000122	0.0161	CbGpPWpGaD
Diethylpropion—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000122	0.00122	CcSEcCtD
Diethylpropion—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000122	0.00122	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000122	0.00122	CcSEcCtD
Diethylpropion—Erythema—Losartan—type 2 diabetes mellitus	0.000122	0.00122	CcSEcCtD
Diethylpropion—Headache—Glipizide—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Diethylpropion—Tremor—Irbesartan—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Diethylpropion—Palpitations—Metformin—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Diethylpropion—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000121	0.00121	CcSEcCtD
Diethylpropion—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Diethylpropion—Tension—Losartan—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Diethylpropion—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Diethylpropion—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Diethylpropion—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00012	0.00119	CcSEcCtD
Diethylpropion—Agitation—Irbesartan—type 2 diabetes mellitus	0.000119	0.00119	CcSEcCtD
Diethylpropion—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000119	0.00119	CcSEcCtD
Diethylpropion—Urticaria—Glyburide—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Diethylpropion—Nervousness—Losartan—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000118	0.0156	CbGpPWpGaD
Diethylpropion—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000118	0.00118	CcSEcCtD
Diethylpropion—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Diethylpropion—Chest pain—Metformin—type 2 diabetes mellitus	0.000117	0.00117	CcSEcCtD
Diethylpropion—Myalgia—Metformin—type 2 diabetes mellitus	0.000117	0.00117	CcSEcCtD
Diethylpropion—Malaise—Irbesartan—type 2 diabetes mellitus	0.000117	0.00117	CcSEcCtD
Diethylpropion—Headache—Pioglitazone—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Diethylpropion—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000116	0.00116	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Diethylpropion—Discomfort—Metformin—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000116	0.0152	CbGpPWpGaD
Diethylpropion—Nausea—Glipizide—type 2 diabetes mellitus	0.000115	0.00115	CcSEcCtD
Diethylpropion—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000115	0.00115	CcSEcCtD
Diethylpropion—Vision blurred—Losartan—type 2 diabetes mellitus	0.000115	0.00115	CcSEcCtD
Diethylpropion—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00114	CcSEcCtD
Diethylpropion—Constipation—Gliclazide—type 2 diabetes mellitus	0.000115	0.00114	CcSEcCtD
Diethylpropion—Tremor—Losartan—type 2 diabetes mellitus	0.000115	0.00114	CcSEcCtD
Diethylpropion—Rash—Glimepiride—type 2 diabetes mellitus	0.000114	0.00114	CcSEcCtD
Diethylpropion—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000114	0.00114	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000114	0.015	CbGpPWpGaD
Diethylpropion—Rash—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00114	CcSEcCtD
Diethylpropion—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Diethylpropion—Headache—Glimepiride—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Diethylpropion—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000113	0.00113	CcSEcCtD
Diethylpropion—Headache—Sitagliptin—type 2 diabetes mellitus	0.000113	0.00113	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000112	0.00112	CcSEcCtD
Diethylpropion—Agitation—Losartan—type 2 diabetes mellitus	0.000112	0.00112	CcSEcCtD
Diethylpropion—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00111	CcSEcCtD
Diethylpropion—Insomnia—Valsartan—type 2 diabetes mellitus	0.000112	0.00111	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000111	0.00111	CcSEcCtD
Diethylpropion—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Diethylpropion—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Diethylpropion—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Diethylpropion—Insomnia—Orlistat—type 2 diabetes mellitus	0.00011	0.0011	CcSEcCtD
Diethylpropion—Malaise—Losartan—type 2 diabetes mellitus	0.00011	0.0011	CcSEcCtD
Diethylpropion—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00011	0.0011	CcSEcCtD
Diethylpropion—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00011	0.0011	CcSEcCtD
Diethylpropion—Somnolence—Valsartan—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Diethylpropion—Leukopenia—Losartan—type 2 diabetes mellitus	0.000109	0.00109	CcSEcCtD
Diethylpropion—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000109	0.00109	CcSEcCtD
Diethylpropion—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Diethylpropion—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—SLC5A4—type 2 diabetes mellitus	0.000109	0.0142	CbGpPWpGaD
Diethylpropion—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000108	0.00108	CcSEcCtD
Diethylpropion—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000108	0.00108	CcSEcCtD
Diethylpropion—Palpitations—Losartan—type 2 diabetes mellitus	0.000108	0.00108	CcSEcCtD
Diethylpropion—Nausea—Glimepiride—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Diethylpropion—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Diethylpropion—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000107	0.00107	CcSEcCtD
Diethylpropion—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000107	0.00107	CcSEcCtD
Diethylpropion—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Diethylpropion—SLC6A2—Monoamine Transport—AGT—type 2 diabetes mellitus	0.000106	0.014	CbGpPWpGaD
Diethylpropion—Alopecia—Ramipril—type 2 diabetes mellitus	0.000106	0.00106	CcSEcCtD
Diethylpropion—Constipation—Valsartan—type 2 diabetes mellitus	0.000106	0.00105	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000105	0.00105	CcSEcCtD
Diethylpropion—Erythema—Ramipril—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Diethylpropion—Chest pain—Losartan—type 2 diabetes mellitus	0.000104	0.00104	CcSEcCtD
Diethylpropion—Myalgia—Losartan—type 2 diabetes mellitus	0.000104	0.00104	CcSEcCtD
Diethylpropion—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000104	0.00104	CcSEcCtD
Diethylpropion—Anxiety—Losartan—type 2 diabetes mellitus	0.000104	0.00103	CcSEcCtD
Diethylpropion—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000104	0.00103	CcSEcCtD
Diethylpropion—Rash—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00103	CcSEcCtD
Diethylpropion—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00103	CcSEcCtD
Diethylpropion—Tension—Ramipril—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Diethylpropion—Discomfort—Losartan—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Diethylpropion—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Diethylpropion—Headache—Bromocriptine—type 2 diabetes mellitus	0.000103	0.00102	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000102	0.0135	CbGpPWpGaD
Diethylpropion—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000102	0.00102	CcSEcCtD
Diethylpropion—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000102	0.00102	CcSEcCtD
Diethylpropion—Nervousness—Ramipril—type 2 diabetes mellitus	0.000102	0.00101	CcSEcCtD
Diethylpropion—Dry mouth—Losartan—type 2 diabetes mellitus	0.000102	0.00101	CcSEcCtD
Diethylpropion—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.0001	0.001	CcSEcCtD
Diethylpropion—Dyspnoea—Metformin—type 2 diabetes mellitus	0.0001	0.000998	CcSEcCtD
Diethylpropion—Somnolence—Metformin—type 2 diabetes mellitus	9.99e-05	0.000995	CcSEcCtD
Diethylpropion—Methamphetamine—ADRA2A—type 2 diabetes mellitus	9.98e-05	0.0391	CrCbGaD
Diethylpropion—Dyspepsia—Metformin—type 2 diabetes mellitus	9.89e-05	0.000985	CcSEcCtD
Diethylpropion—Tremor—Ramipril—type 2 diabetes mellitus	9.82e-05	0.000978	CcSEcCtD
Diethylpropion—Urticaria—Valsartan—type 2 diabetes mellitus	9.8e-05	0.000976	CcSEcCtD
Diethylpropion—Tachycardia—Losartan—type 2 diabetes mellitus	9.74e-05	0.00097	CcSEcCtD
Diethylpropion—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000969	CcSEcCtD
Diethylpropion—Nausea—Bromocriptine—type 2 diabetes mellitus	9.72e-05	0.000968	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.7e-05	0.000966	CcSEcCtD
Diethylpropion—Urticaria—Orlistat—type 2 diabetes mellitus	9.69e-05	0.000965	CcSEcCtD
Diethylpropion—SLC6A3—Neuronal System—KCNK16—type 2 diabetes mellitus	9.69e-05	0.0127	CbGpPWpGaD
Diethylpropion—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.66e-05	0.000962	CcSEcCtD
Diethylpropion—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.65e-05	0.000961	CcSEcCtD
Diethylpropion—Agitation—Ramipril—type 2 diabetes mellitus	9.64e-05	0.000959	CcSEcCtD
Diethylpropion—Constipation—Metformin—type 2 diabetes mellitus	9.61e-05	0.000957	CcSEcCtD
Diethylpropion—Vomiting—Glyburide—type 2 diabetes mellitus	9.51e-05	0.000947	CcSEcCtD
Diethylpropion—Selegiline—CYP2E1—type 2 diabetes mellitus	9.46e-05	0.0371	CrCbGaD
Diethylpropion—Malaise—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000941	CcSEcCtD
Diethylpropion—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.45e-05	0.000941	CcSEcCtD
Diethylpropion—SLC6A3—Monoamine Transport—AGT—type 2 diabetes mellitus	9.43e-05	0.0124	CbGpPWpGaD
Diethylpropion—Rash—Glyburide—type 2 diabetes mellitus	9.43e-05	0.000939	CcSEcCtD
Diethylpropion—Somnolence—Irbesartan—type 2 diabetes mellitus	9.43e-05	0.000939	CcSEcCtD
Diethylpropion—Dermatitis—Glyburide—type 2 diabetes mellitus	9.42e-05	0.000938	CcSEcCtD
Diethylpropion—Leukopenia—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000935	CcSEcCtD
Diethylpropion—Headache—Glyburide—type 2 diabetes mellitus	9.37e-05	0.000933	CcSEcCtD
Diethylpropion—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.34e-05	0.000929	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	9.28e-05	0.0122	CbGpPWpGaD
Diethylpropion—Palpitations—Ramipril—type 2 diabetes mellitus	9.27e-05	0.000923	CcSEcCtD
Diethylpropion—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.26e-05	0.000922	CcSEcCtD
Diethylpropion—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.19e-05	0.000915	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.000912	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.09e-05	0.000905	CcSEcCtD
Diethylpropion—Convulsion—Ramipril—type 2 diabetes mellitus	9.09e-05	0.000905	CcSEcCtD
Diethylpropion—Constipation—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000903	CcSEcCtD
Diethylpropion—Insomnia—Losartan—type 2 diabetes mellitus	9.03e-05	0.000899	CcSEcCtD
Diethylpropion—Selegiline—CYP1A2—type 2 diabetes mellitus	9e-05	0.0353	CrCbGaD
Diethylpropion—Urticaria—Metformin—type 2 diabetes mellitus	8.93e-05	0.000889	CcSEcCtD
Diethylpropion—Myalgia—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000889	CcSEcCtD
Diethylpropion—Chest pain—Ramipril—type 2 diabetes mellitus	8.93e-05	0.000889	CcSEcCtD
Diethylpropion—Dyspnoea—Losartan—type 2 diabetes mellitus	8.9e-05	0.000886	CcSEcCtD
Diethylpropion—Anxiety—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000886	CcSEcCtD
Diethylpropion—Nausea—Glyburide—type 2 diabetes mellitus	8.88e-05	0.000885	CcSEcCtD
Diethylpropion—Dizziness—Gliclazide—type 2 diabetes mellitus	8.88e-05	0.000884	CcSEcCtD
Diethylpropion—Somnolence—Losartan—type 2 diabetes mellitus	8.87e-05	0.000883	CcSEcCtD
Diethylpropion—Discomfort—Ramipril—type 2 diabetes mellitus	8.82e-05	0.000878	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	8.8e-05	0.0115	CbGpPWpGaD
Diethylpropion—Dyspepsia—Losartan—type 2 diabetes mellitus	8.79e-05	0.000875	CcSEcCtD
Diethylpropion—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.74e-05	0.00087	CcSEcCtD
Diethylpropion—Dry mouth—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000869	CcSEcCtD
Diethylpropion—Vomiting—Gliclazide—type 2 diabetes mellitus	8.54e-05	0.00085	CcSEcCtD
Diethylpropion—Constipation—Losartan—type 2 diabetes mellitus	8.53e-05	0.00085	CcSEcCtD
Diethylpropion—Rash—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.000843	CcSEcCtD
Diethylpropion—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.46e-05	0.000842	CcSEcCtD
Diethylpropion—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.44e-05	0.000841	CcSEcCtD
Diethylpropion—Urticaria—Irbesartan—type 2 diabetes mellitus	8.42e-05	0.000839	CcSEcCtD
Diethylpropion—Headache—Gliclazide—type 2 diabetes mellitus	8.41e-05	0.000838	CcSEcCtD
Diethylpropion—Tachycardia—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000832	CcSEcCtD
Diethylpropion—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.34e-05	0.000831	CcSEcCtD
Diethylpropion—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000824	CcSEcCtD
Diethylpropion—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.22e-05	0.000819	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—SLC5A2—type 2 diabetes mellitus	8.22e-05	0.0108	CbGpPWpGaD
Diethylpropion—Dizziness—Valsartan—type 2 diabetes mellitus	8.16e-05	0.000812	CcSEcCtD
Diethylpropion—Dizziness—Orlistat—type 2 diabetes mellitus	8.06e-05	0.000803	CcSEcCtD
Diethylpropion—Nausea—Gliclazide—type 2 diabetes mellitus	7.98e-05	0.000794	CcSEcCtD
Diethylpropion—Urticaria—Losartan—type 2 diabetes mellitus	7.93e-05	0.000789	CcSEcCtD
Diethylpropion—Vomiting—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000781	CcSEcCtD
Diethylpropion—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000776	CcSEcCtD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	7.79e-05	0.0102	CbGpPWpGaD
Diethylpropion—Rash—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000775	CcSEcCtD
Diethylpropion—Dermatitis—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000774	CcSEcCtD
Diethylpropion—Vomiting—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000772	CcSEcCtD
Diethylpropion—Insomnia—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000771	CcSEcCtD
Diethylpropion—Headache—Valsartan—type 2 diabetes mellitus	7.73e-05	0.00077	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	7.72e-05	0.0101	CbGpPWpGaD
Diethylpropion—Diarrhoea—Metformin—type 2 diabetes mellitus	7.69e-05	0.000766	CcSEcCtD
Diethylpropion—Rash—Orlistat—type 2 diabetes mellitus	7.69e-05	0.000766	CcSEcCtD
Diethylpropion—Dermatitis—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000765	CcSEcCtD
Diethylpropion—Headache—Orlistat—type 2 diabetes mellitus	7.64e-05	0.000761	CcSEcCtD
Diethylpropion—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.63e-05	0.00076	CcSEcCtD
Diethylpropion—Somnolence—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000757	CcSEcCtD
Diethylpropion—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.53e-05	0.00075	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	7.46e-05	0.00979	CbGpPWpGaD
Diethylpropion—Dizziness—Metformin—type 2 diabetes mellitus	7.43e-05	0.00074	CcSEcCtD
Diethylpropion—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000736	CcSEcCtD
Diethylpropion—Nausea—Valsartan—type 2 diabetes mellitus	7.33e-05	0.00073	CcSEcCtD
Diethylpropion—Constipation—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000729	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—ABCC2—type 2 diabetes mellitus	7.31e-05	0.00959	CbGpPWpGaD
Diethylpropion—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000722	CcSEcCtD
Diethylpropion—Nausea—Orlistat—type 2 diabetes mellitus	7.24e-05	0.000721	CcSEcCtD
Diethylpropion—Vomiting—Metformin—type 2 diabetes mellitus	7.15e-05	0.000711	CcSEcCtD
Diethylpropion—Rash—Metformin—type 2 diabetes mellitus	7.09e-05	0.000705	CcSEcCtD
Diethylpropion—Dermatitis—Metformin—type 2 diabetes mellitus	7.08e-05	0.000705	CcSEcCtD
Diethylpropion—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.05e-05	0.000702	CcSEcCtD
Diethylpropion—Headache—Metformin—type 2 diabetes mellitus	7.04e-05	0.000701	CcSEcCtD
Diethylpropion—Dizziness—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.000698	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	6.84e-05	0.00898	CbGpPWpGaD
Diethylpropion—Diarrhoea—Losartan—type 2 diabetes mellitus	6.83e-05	0.00068	CcSEcCtD
Diethylpropion—Urticaria—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000677	CcSEcCtD
Diethylpropion—Vomiting—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000671	CcSEcCtD
Diethylpropion—SLC6A3—Neuronal System—KCNQ1—type 2 diabetes mellitus	6.71e-05	0.00881	CbGpPWpGaD
Diethylpropion—Rash—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000666	CcSEcCtD
Diethylpropion—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000665	CcSEcCtD
Diethylpropion—Nausea—Metformin—type 2 diabetes mellitus	6.68e-05	0.000665	CcSEcCtD
Diethylpropion—Headache—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.000661	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	6.6e-05	0.00867	CbGpPWpGaD
Diethylpropion—Dizziness—Losartan—type 2 diabetes mellitus	6.6e-05	0.000657	CcSEcCtD
Diethylpropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	6.53e-05	0.00857	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—ABCC2—type 2 diabetes mellitus	6.47e-05	0.0085	CbGpPWpGaD
Diethylpropion—Vomiting—Losartan—type 2 diabetes mellitus	6.35e-05	0.000632	CcSEcCtD
Diethylpropion—SLC6A2—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	6.34e-05	0.00833	CbGpPWpGaD
Diethylpropion—Nausea—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000627	CcSEcCtD
Diethylpropion—Rash—Losartan—type 2 diabetes mellitus	6.29e-05	0.000627	CcSEcCtD
Diethylpropion—Dermatitis—Losartan—type 2 diabetes mellitus	6.29e-05	0.000626	CcSEcCtD
Diethylpropion—Headache—Losartan—type 2 diabetes mellitus	6.25e-05	0.000623	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	6.08e-05	0.00798	CbGpPWpGaD
Diethylpropion—Selegiline—CYP3A4—type 2 diabetes mellitus	5.96e-05	0.0234	CrCbGaD
Diethylpropion—Nausea—Losartan—type 2 diabetes mellitus	5.93e-05	0.00059	CcSEcCtD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	5.88e-05	0.00772	CbGpPWpGaD
Diethylpropion—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000583	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	5.85e-05	0.00768	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	5.8e-05	0.00762	CbGpPWpGaD
Diethylpropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	5.79e-05	0.00759	CbGpPWpGaD
Diethylpropion—Dizziness—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000563	CcSEcCtD
Diethylpropion—SLC6A3—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	5.62e-05	0.00737	CbGpPWpGaD
Diethylpropion—Vomiting—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000542	CcSEcCtD
Diethylpropion—Rash—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000537	CcSEcCtD
Diethylpropion—Dermatitis—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000537	CcSEcCtD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	5.38e-05	0.00707	CbGpPWpGaD
Diethylpropion—Headache—Ramipril—type 2 diabetes mellitus	5.36e-05	0.000534	CcSEcCtD
Diethylpropion—SLC6A3—Alpha-synuclein signaling—SRC—type 2 diabetes mellitus	5.25e-05	0.00689	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	5.21e-05	0.00684	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	5.18e-05	0.0068	CbGpPWpGaD
Diethylpropion—SLC6A3—Parkinsons Disease Pathway—CASP3—type 2 diabetes mellitus	5.12e-05	0.00672	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—ABCC8—type 2 diabetes mellitus	5.09e-05	0.00668	CbGpPWpGaD
Diethylpropion—Nausea—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000506	CcSEcCtD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	4.97e-05	0.00653	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	4.91e-05	0.00645	CbGpPWpGaD
Diethylpropion—SLC6A2—Monoamine Transport—TNF—type 2 diabetes mellitus	4.83e-05	0.00633	CbGpPWpGaD
Diethylpropion—SLC6A3—Dopaminergic Neurogenesis—TGFB1—type 2 diabetes mellitus	4.82e-05	0.00633	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	4.8e-05	0.00631	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	4.71e-05	0.00618	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—GAD2—type 2 diabetes mellitus	4.45e-05	0.00584	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	4.41e-05	0.00578	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	4.35e-05	0.00571	CbGpPWpGaD
Diethylpropion—SLC6A3—Monoamine Transport—TNF—type 2 diabetes mellitus	4.27e-05	0.00561	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	4.26e-05	0.00559	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	4.17e-05	0.00548	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	4.1e-05	0.00538	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—HMOX1—type 2 diabetes mellitus	4.04e-05	0.0053	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—KCNJ11—type 2 diabetes mellitus	4.02e-05	0.00528	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	4e-05	0.00525	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.92e-05	0.00515	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3.82e-05	0.00501	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	3.79e-05	0.00497	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	3.79e-05	0.00497	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—GSTM1—type 2 diabetes mellitus	3.76e-05	0.00494	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	3.74e-05	0.00491	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	3.72e-05	0.00489	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—AGER—type 2 diabetes mellitus	3.63e-05	0.00476	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	3.63e-05	0.00476	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—HMOX1—type 2 diabetes mellitus	3.58e-05	0.0047	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.54e-05	0.00465	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.47e-05	0.00456	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.46e-05	0.00455	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3.38e-05	0.00444	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	3.36e-05	0.0044	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	3.36e-05	0.0044	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—GSTM1—type 2 diabetes mellitus	3.34e-05	0.00438	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	3.3e-05	0.00433	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—AGER—type 2 diabetes mellitus	3.22e-05	0.00422	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	3.1e-05	0.00406	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	3.09e-05	0.00405	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	3.09e-05	0.00405	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	3.07e-05	0.00403	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.97e-05	0.0039	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.97e-05	0.0039	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.97e-05	0.0039	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.92e-05	0.00383	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—SNAP25—type 2 diabetes mellitus	2.87e-05	0.00376	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	2.8e-05	0.00367	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.74e-05	0.0036	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.74e-05	0.00359	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.74e-05	0.00359	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.7e-05	0.00354	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.63e-05	0.00346	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.63e-05	0.00346	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.63e-05	0.00345	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.59e-05	0.0034	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.53e-05	0.00332	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.52e-05	0.00331	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	2.49e-05	0.00327	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.44e-05	0.0032	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.39e-05	0.00314	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.34e-05	0.00307	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	2.24e-05	0.00294	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	2.24e-05	0.00293	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	2.16e-05	0.00284	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—GNB3—type 2 diabetes mellitus	2.14e-05	0.00281	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	2.14e-05	0.00281	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	2.07e-05	0.00272	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	2.03e-05	0.00267	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	2.01e-05	0.00264	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.94e-05	0.00255	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.94e-05	0.00255	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—ADCY5—type 2 diabetes mellitus	1.91e-05	0.00251	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.89e-05	0.00248	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.88e-05	0.00247	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.87e-05	0.00246	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.8e-05	0.00236	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.72e-05	0.00225	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.72e-05	0.00225	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.68e-05	0.0022	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.67e-05	0.00219	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.66e-05	0.00218	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.65e-05	0.00216	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—CALM1—type 2 diabetes mellitus	1.64e-05	0.00215	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.57e-05	0.00206	CbGpPWpGaD
Diethylpropion—SLC6A3—Neuronal System—PRKCB—type 2 diabetes mellitus	1.54e-05	0.00202	CbGpPWpGaD
Diethylpropion—SLC6A2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	1.53e-05	0.00201	CbGpPWpGaD
Diethylpropion—SLC6A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.53e-05	0.00201	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.51e-05	0.00198	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.46e-05	0.00192	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.39e-05	0.00183	CbGpPWpGaD
Diethylpropion—SLC6A3—NRF2 pathway—TGFB1—type 2 diabetes mellitus	1.36e-05	0.00178	CbGpPWpGaD
Diethylpropion—SLC6A3—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.35e-05	0.00178	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.34e-05	0.00175	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.3e-05	0.00171	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.29e-05	0.0017	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.28e-05	0.00168	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.24e-05	0.00163	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.16e-05	0.00152	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.15e-05	0.00151	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.15e-05	0.0015	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.14e-05	0.00149	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.1e-05	0.00144	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.05e-05	0.00137	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.03e-05	0.00135	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.81e-06	0.00129	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.26e-06	0.00122	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.69e-06	0.00114	CbGpPWpGaD
Diethylpropion—SLC6A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.77e-06	0.00102	CbGpPWpGaD
Diethylpropion—SLC6A3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.88e-06	0.000903	CbGpPWpGaD
